Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2058 of 6351
-
Weight loss before IVF boosts baby chances for overweight women
Disease control CompletedThe aim of this study is to determine whether weight loss prior to in vitro fertilization (IVF) improves live birth outcomes in overweight and obese infertile women. The study prospectively analyzed 158 overweight and obese (BMI ≥ 24 kg/m2) infertile women, age between 20 and 36 …
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
Can magnetic pulses ease alcohol and brain injury struggles in veterans?
Disease control By invitation onlyThe objectives of this VA Merit application are to identify a neural target unique to Veterans with co-occurring alcohol use disorder and mild traumatic brain injury (AUD+mTBI) and to test the efficacy of this target as a stimulation site for repetitive transcranial magnetic stim…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Engineered immune cells take on brain cancer in early trial
Disease control CompletedIn this study, is researching the safety of tisagenlecleucel in participants with primary central nervous system lymphoma. . -The name of the study intervention is tisagenlecleucel.
Phase 1 • Sponsor: Matthew J. Frigault, M.D. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Skin clues could unmask rare nerve disease in kids
Knowledge-focused Recruiting now.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000. the clinical presentation is based on the appearance of tumors in the central and peripheral nerv…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Liver size may hold key to immunotherapy response
Knowledge-focused Recruiting nowThis multicenter retrospective cohort study aims to evaluate the prognostic value of functional liver volume and total liver volume in patients with unresectable hepatocellular carcinoma (HCC) undergoing immunotherapy. The study explores whether baseline liver volume metrics can …
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Could a simple injection after a broken ankle prevent arthritis?
Disease control Recruiting nowHigh energy intra-articular fractures of the distal tibia, or Pilon fracture, is a devastating injury with multiple short and long term complications. The incidence of these injuries is increasing as survival rates after motor vehicle collisions increase. The current standard of …
Phase 4 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Experimental drug shows promise for Tough-to-Treat lymphoma
Disease control CompletedThe purpose of this study is to test any good and bad effects of the study drug, CPI-613.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New dengue vaccine shows promise in early trial
Vaccine CompletedThe purpose of this study is to assess the neutralizing antibody response against each dengue serotype post-vaccination.
Phase 2 • Sponsor: Takeda • Aim: Vaccine
Last updated Jun 26, 2026 14:42 UTC
-
MS drug ofatumumab tested for Long-Term safety in nearly 1,900 patients
Disease control OngoingThe purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the e…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Experimental combo therapy targets hard-to-treat sarcoma
Disease control CompletedATLAS-IT-04 is a two part, single arm study designed to determine the safety and effectiveness of LTX-315 to induce T-cell infiltration prior to TIL expansion in patients with soft tissue sarcoma. Following intratumoural injection of LTX-315 to a selected lesion, the lesion will …
Phase 2 • Sponsor: Lytix Biopharma AS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Herbal extract may ease the toll of lung cancer immunotherapy
Symptom relief CompletedThis randomized, open labelled, non-treatment-controlled study evaluates the safety and efficacy of Lindera obtusiloba, a dietary food, on quality of life of non-small cell lung cancer patients who are receiving PD-1 or PD-L1 inhibitors.
Sponsor: Jun-Yong Choi • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedThe purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).
Phase 2 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Custom vaccine shows promise in halting rare blood cancer
Vaccine CompletedThis early phase I trial studies the side effects of personalized vaccine in treating patients with smoldering multiple myeloma. Vaccines made from a person's blood and bone marrow may help the body build an effective immune response to kill cancer cells.
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC
-
New MRI technique could sharpen radiation for Kids' brain tumors
Knowledge-focused Recruiting nowThis trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, such as spectroscopic MRI may help to map the differences in tumor metabolism co…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Simple cuff trick may boost walking after stroke
Symptom relief CompletedThis innovative study will address scientific and clinical areas relatively unexplored in chronic stroke that could lead to greater recovery of walking. Ischemic Conditioning (IC) is a non-invasive, simple procedure that improves motor function, exercise performance and cardiovas…
Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo shows promise for Tough-to-Treat stomach cancer
Disease control CompletedThe purpose of this study is to find out if the combination of TAS 102 and Ramucirumab is safe and effective in patients with advanced, refractory gastric or gastroesophageal junction (GEJ) adenocarcinoma.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New blood test could replace risky amniocentesis for genetic disorders
Diagnosis Stopped earlyThe purprose of this study is to develop a single test based on circulating fetal trophoblastic cells (CFTC) analysis from maternal blood, searching for the familial mutation for a wide range of monogenic diseases.
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New hope for lupus patients: two experimental drugs show promise in reducing disease activity
Disease control CompletedThis study is designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic efficacy of treatment with either VAY736 (ianalumab) or CFZ533 (iscalimab) in patients with systemic lupus erythematosus (SLE) to enable further development of these compounds as treatme…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo takes aim at High-Risk leukemia
Disease control OngoingIbrutinib, a first-in-class Bruton Tyrosine kinase (BTK) inhibitor, has become an established treatment in relapsed/refractory chronic lymphocytic leukemia (CLL). However, despite a considerable improvement of Progression Free Survival (PFS) and Overall Survival (OS) in compariso…
Phase 2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Patch may boost fetal spina bifida repair, early trial hints
Disease control OngoingThe purpose of the study is to compare the maternal, fetal and neonatal outcomes of a cohort of 60 patients in whom a multilayer closure with a Durepair patch is performed with a prior cohort of patients in whom a standardized repair without patch (n = 32) was performed using the…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC